Regulation of Probiotics in the USA: Dietary Supplements

By Ivan Wasserman, counsel to the International Probiotics Association, and partner at Amin, Talati and Upadhye LLP

- Last updated on GMT

© iStock
© iStock

Related tags: Dietary supplements, Food and drug administration, Dietary supplement

The United States Food and Drug Administration’s (FDA) regulation of products containing probiotics is complex and largely depends on the claims that are made for the product. For example, they can be regulated as foods, dietary supplements, cosmetics, or drugs/biologics (a class of drugs which are extracted from or derivatives of living organisms). In this second of a four part IPA Counsel Corner series, we will focus on the second category: dietary supplements.

FDA defines a dietary supplement as “a product intended for ingestion that contains a ‘dietary ingredient’ intended to add further nutritional value to (supplement) the diet.” Dietary Supplements are typically sold as tablets, capsules, powders, and liquids (although there are additional considerations in determining if a product is a liquid supplement or a conventional food beverage). Like other ingredients, before marketing a dietary supplement with a probiotic ingredient a determination must be made if it requires the submission of a New Dietary Ingredient notification to FDA with information on the safety of the ingredient. A notification is not required if the probiotic was sold in the United States as a dietary supplement prior to October 15, 1994, or if it is present in the food supply as an article used for food in a form in which the food has not been chemically altered. FDA’s current position is that certain changes in how an ingredient is processed, may trigger the need to submit a notification.

Ivan Wasserman
Ivan Wasserman, IPA Counsel

Like foods, dietary supplements cannot claim to treat, cure, mitigate or prevent a “disease,” but can claim to “affect the structure or any function of the body of man or other animals.” Common probiotic structure/function claims include “support healthy digestion” and “support a healthy immune system.” Unlike foods, dietary supplements making structure/function claims must bear a mandatory disclaimer: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat cure, or prevent any disease.” Also, the manufacturer must notify FDA within 30 days of making the claim. As with all claims, structure/function claim for dietary supplements must be truthful, non-misleading, and substantiated with competent and reliable scientific evidence.

This article was originally published by the International Probiotics Association in its IPA Counsel Corner​ blog. Reproduced with permission.

Related news

Related products

show more

KaraHeart™ Showed Results in Just 30 Days

KaraHeart™ Showed Results in Just 30 Days

Karallief® Inc | 30-Jun-2022 | Data Sheet

After extensive R&D, scientists at Karallief® developed KaraHeart™ – a patent-pending and clinically tested vegan herbal blend that effectively manages...

Insider Guide: Science-backed Supplement Solution

Insider Guide: Science-backed Supplement Solution

SR CarnoSyn® | 16-Jun-2022 | Infographic

Check out this easy-to-read overview of SR CarnoSyn®, the globally patented, clinically confirmed supplement for wellness and healthy aging. The insider...

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Related suppliers

Follow us

Products

View more

Webinars